# CLINDAMYCIN PHOSPHATE AND TRETINOIN
> **ANDA202564** · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS MID ATLANTIC · Approved 2015-06-12
## Drug
- **FDA Application Number:** ANDA202564
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CLINDAMYCIN PHOSPHATE AND TRETINOIN
- **Generic name:** CLINDAMYCIN PHOSPHATE AND TRETINOIN
- **Active ingredients:** CLINDAMYCIN PHOSPHATE; TRETINOIN
- **Dosage form:** GEL
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** ACTAVIS MID ATLANTIC
- **Manufacturer:** Actavis Pharma, Inc.
- **First approval:** 2015-06-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202564)
---
*AI Analytics · CC0 1.0*